Stay updated on ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial

Sign up to get notified when there's something new on the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH transition notice about using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T16:52:10.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T21:56:08.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T04:25:20.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden message, replacing the usual content, and the Home link appears to be removed, indicating restricted access to the page.
    Difference
    0.5%
    Check dated 2026-09-28T22:38:17.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, replacing the previous content with an error screen and signaling restricted access to the record.
    Difference
    20%
    Check dated 2026-09-21T22:28:45.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page’s revision stamp was updated to v3.6.6, signaling a new version of the page. This appears to be a routine update rather than a substantive change to the trial details or user-facing information.
    Difference
    0.0%
    Check dated 2026-08-31T17:19:36.000Z thumbnail image

Stay in the know with updates to ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page.